Extended
Hospital Stay
Dysphagia Therapy Like No Other
Non-surgical, neurostimulation therapy
to restore swallowing control and reduce length of stay.
Targeting and restoring the neurological components of swallowing coordination and control that are disrupted due to brain injury or prolonged mechanical ventilation.
Robust Evidence
Randomized control trials demonstrate clinically significant improvements using a range of dysphagia outcome measures.
Favorable Economics
Treatment can be delivered earlier than other dysphagia interventions and has been shown to support faster recovery and reduced length of stay.
Seamless Integration
Simple to integrate into existing multidisciplinary care. Treatment sessions are targeted, quick and require limited patient input to optimize and deliver.
Dysphagia is Common, Costly, and Harmful to Patients
Swallowing impairment, called dysphagia, affects millions of people worldwide and can have a profound health and economic impact.
Treating the Root Cause of Dysphagia.
Phagenyx® Neurostimulation System
Introducing the first and only treatment using Pharyngeal Electrical Stimulation (PES) to restore swallowing control, facilitate airway protection, and accelerate recovery.
Personalized levels of PES, delivered at the earliest stages after injury, enhance neurorehabilitation and reorganization of swallowing control, while requiring minimal patient participation.
Patient-Tailored Stimulation
Measures Individual Sensory Capacity
Dual-Function Catheter
Feeding Delivery + Stimulation Delivery
View Animation
Video Duration: 02:40
View Setup Video
Video Duration: 05:50
Simple & Safe
Non-surgical therapy with 10+ years of clinical use in Europe
Adjust the catheter to reflect patient anatomy and then insert. When ready to deliver treatment, connect the catheter to the Base Station.
Follow Base Station on-screen instructions to measure patient sensory capacity and optimize the stimulation level.
Deliver optimized stimulation for 10 minutes once per day. On completion, disconnect the Base Station. Leave the catheter in place.
Repeat for 3-6 days as clinically indicated. On completion of the treatment regimen, remove the catheter or leave in place for feeding for up to 30 days.
Extensive Clinical Evidence
Demonstrated Safety in Multiple Patient Populations
0
Years
0
Randomized
Control Trials
Control Trials
0
Publications
September 2, 2024 | Press Release
Phagenesis ernennt Chad Hoskins zum Chief Executive Officer nach Abschluss einer Serie-D-Finanzierungsrunde in Höhe von 42 Mio. USD
Manchester, UK – 5. September 2024 – Das britische Pionierunternehmen Phagenesis, das ein neuartiges Neurostimulationssystem zur Behandlung von Schluckstörungen entwickelt hat, gab heute die Ernennung von Chad Hoskins zum Chief Executive Officer (CEO) bekannt. Der erfahrene Manager bringt jahrzehntelange Expertise in der Skalierung innovativer MedTech-Therapien, der Förderung des kommerziellen Wachstums in den USA und der Erreichung strategischer Ziele mit. „Wir freuen uns sehr, dass Chad dem Unternehmen in dieser kritischen Wachstumsphase beitritt, in der wir auf unserem Erfolg in Europa aufbauen und die Anwendung von Phagenyx® in den USA ausweiten“, sagte Dr. Oern Stuge, Vorstandsvorsitzender von Phagenesis. Sein unermüdlicher Einsatz…